Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 30.87B | HK$ 34.60B | HK$ 31.59B | HK$ 33.59B | HK$ 28.03B |
| Gross Profit | HK$ 21.60B | HK$ 24.40B | HK$ 22.73B | HK$ 25.47B | HK$ 21.00B |
| Operating Income | HK$ 5.71B | HK$ 7.68B | HK$ 6.76B | HK$ 6.25B | HK$ 5.47B |
| EBITDA | HK$ 6.96B | HK$ 8.53B | HK$ 8.66B | HK$ 9.28B | HK$ 8.09B |
| Net Income | HK$ 4.61B | HK$ 5.87B | HK$ 6.09B | HK$ 5.61B | HK$ 5.16B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 8.60B | HK$ 13.09B | HK$ 13.68B | HK$ 13.87B | HK$ 10.47B |
| Total Assets | HK$ 44.39B | HK$ 46.28B | HK$ 41.77B | HK$ 42.50B | HK$ 35.65B |
| Total Debt | HK$ 507.33M | HK$ 706.90M | HK$ 659.28M | HK$ 115.04M | HK$ 375.51M |
| Net Debt | HK$ -6.27B | HK$ -11.31B | HK$ -9.58B | HK$ -11.24B | HK$ -8.27B |
| Total Liabilities | HK$ 10.52B | HK$ 11.26B | HK$ 11.07B | HK$ 9.37B | HK$ 8.28B |
| Stockholders' Equity | HK$ 32.26B | HK$ 33.20B | HK$ 29.77B | HK$ 31.79B | HK$ 26.48B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 1.86B | HK$ 2.29B | HK$ 5.32B | HK$ 3.74B | HK$ 5.91B |
| Operating Cash Flow | HK$ 4.53B | HK$ 4.18B | HK$ 7.63B | HK$ 4.64B | HK$ 6.74B |
| Investing Cash Flow | HK$ -3.86B | HK$ 607.27M | HK$ -6.80B | HK$ -637.33M | HK$ -2.13B |
| Financing Cash Flow | HK$ -5.25B | HK$ -2.30B | HK$ -1.90B | HK$ -2.20B | HK$ -1.47B |